Antares Pharma reported $174.27M in Current Assets for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Abbott ABT:US $ 23429M 810M
Abbvie ABBV:US $ 26509M 1419M
Adma Biologics ADMA:US $ 239.8M 31.07M
Aerie Pharmaceuticals AERI:US $ 316.97M 38.68M
Ani Pharmaceuticals ANIP:US $ 301.4M 20.38M
Atrion ATRI:US 136.57M 2.8M
Becton, Dickinson and BDX:US $ 10152M 1845M
Cara Therapeutics CARA:US $ 151.76M 21.53M
Cerus CERS:US $ 172.81M 14.29M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Endo International Ordinary Shares ENDP:US $ 2492.79M 221.79M
Horizon Pharma HZNP:US $ 2947.73M 147.96M
JAZZ PHA JAZZ:US $ 2500.86M 110.48M
Meridian Bioscience VIVO:US $ 217.56M 13.91M
Orasure Technologies OSUR:US $ 268.36M 20.07M
Pacira Pharmaceuticals PCRX:US $ 667.02M 199.03M
Pfizer PFE:US $ 54420M 5273M
Revance Therapeutics RVNC:US $ 285.33M 39.21M
Sientra SIEN:US 134.94M 5.84M
Staar Surgical STAA:US $ 273.9M 2.49M
Supernus Pharmaceuticals SUPN:US $ 568.52M 33.07M
Teva Pharmaceutical TEVA:IT 12.45B 122M
Teva Pharmaceutical Industries TEVA:US $ 12451M 122M
Utah Medical Products UTMD:US $ 75.85M 9.23M